Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari
  • Home
  • Resources
  • Webinar & Video
  • Recent Data Transforming the Management of Kidney Disease in Patients with Type 2 Diabetes

Recent Data Transforming the Management of Kidney Disease in Patients with Type 2 Diabetes

Dr. David Wheeler

Dr. David Wheeler

MBChB, MRCP, MD, FRCGP

Professor of Kidney Medicine at University College London and Honorary

Consultant Nephrologist at the Royal Free London NHS Foundation Trust, UK

Prescribing information for Invokana (canagliflozin)